118TiP A multicenter, randomized, double-blind, placebo-controlled phase III trial of camrelizumab plus chemotherapy with or without radiation therapy (RT) as first-line treatment for patients with brain metastatic non-small cell lung cancer (BM-NSCLC; CTONG2003): Trial in progress
Title:
118TiP A multicenter, randomized, double-blind, placebo-controlled phase III trial of camrelizumab plus chemotherapy with or without radiation therapy (RT) as first-line treatment for patients with brain metastatic non-small cell lung cancer (BM-NSCLC; CTONG2003): Trial in progress
Author:
Yang, J. Pan, Y. Ning, F. Lin, L. Hu, X. Ma, S. Yu, Q. Wang, C. Wang, X. Ma, R. Zhang, X. Lin, G. Zhao, J. Chen, Y. Cui, J. Wu, G. Yang, N. Wu, Y-L.